Third Security, LLC Oragenics Inc Transaction History

Third Security, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$0.39 - $0.6 $1.8 Million - $2.77 Million	-4,612,166 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$0.43 - $0.75 $1.32 Million - $2.3 Million	3,064,000 Added 197.91%	4,612,166 $2.68 Million
Q1 2018 May 01, 2018	BUY	$1.6 - $3.17 $2.48 Million - $4.91 Million	1,548,166 New	1,548,166 $2.69 Million

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $40.7M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Third Security, LLC, based on Form 13F filings with the SEC.

Stay updated on Third Security, LLC with notifications on news.